NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

Phase 1

Completed

Conditions: HIV Infections
HIV Seronegativity
Lipodystrophy

First Posted Date: 2001-08-31

Last Posted Date: 2006-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 56

Registration Number: NCT00017758

Locations: 🇺🇸
Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
🇺🇸
Univ of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Washington Univ School of Medicine, St Louis, Missouri, United States

and more 7 locations

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 18

Registration Number: NCT00000663

Locations: 🇺🇸
Texas Children's Hosp / Baylor Univ, Houston, Texas, United States
🇺🇸
Cook County Hosp, Chicago, Illinois, United States
🇺🇸
UCSD Treatment Ctr, San Diego, California, United States

and more 4 locations

Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.

Completed

Conditions: HIV Infections
Pregnancy

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 24

Registration Number: NCT00000830

Locations: 🇺🇸
Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark, New Jersey, United States
🇺🇸
Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States
🇺🇸
Mount Sinai Med Ctr / Pediatrics, New York, New York, United States

and more 3 locations

Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 350

Registration Number: NCT00000858

Locations: 🇺🇸
Univ of California / San Francisco, San Francisco, California, United States
🇺🇸
Georgetown Univ Med Ctr, Washington, District of Columbia, United States
🇺🇸
SUNY / Health Sciences Ctr at Brooklyn, Brooklyn, New York, United States

A "Pre-Enrollment" Protocol for HIV-Infected Adolescents

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 250

Registration Number: NCT00000780

Locations: 🇺🇸
Children's Hosp of Boston, Boston, Massachusetts, United States
🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
🇺🇸
UCLA Med Ctr / Pediatric, Los Angeles, California, United States

and more 48 locations

A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies

Phase 3

Completed

Conditions: Pneumonia, Pneumocystis Carinii
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-09-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00001016

Locations: 🇺🇸
Warner-Lambert Parke-Davis, Morris Plains, New Jersey, United States

Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs

Completed

Conditions: HIV Infections
Histoplasmosis

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 50

Registration Number: NCT00006316

Locations: 🇺🇸
Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
🇺🇸
Emory Univ, Atlanta, Georgia, United States
🇺🇸
Cook County Hosp, Chicago, Illinois, United States

and more 10 locations

A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients

Completed

Conditions: Cytomegalovirus Infections
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 400

Registration Number: NCT00001089

Locations: 🇺🇸
Louis A Weiss Memorial Hosp, Chicago, Illinois, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis, Indiana, United States

and more 33 locations

Study of Women Who Have AIDS

Terminated

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1250

Registration Number: NCT00001050

Locations: 🇺🇸
SUNY - Brooklyn, Brooklyn, New York, United States

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 40

Registration Number: NCT00000984

Locations: 🇺🇸
Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl, Newark, New Jersey, United States
🇺🇸
Duke Univ Med Ctr, Durham, North Carolina, United States
🇺🇸
Northern California Pediatric AIDS Treatment Ctr / UCSF, San Francisco, California, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy